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Pi!il<i<k,,~lii<,. .+!,rirl k‘uiirr 
tun rnpable ofdeM”ertng anti *chyc*rdia pacing, ar we,, a* low 
end high energ? W&S and backup bradycardia paring. These 
expanded treatment options hew ted to a wider range of dinicat 
applicationa fur such devices, induding the treatment of ventric- 
ular tarhgcsrdias with longer tprle lagthE, which may overlap 
the cyete lengths of sane rupraventricular arrhythmias. The 
diagnortic capability of these d&w, although improved, has not 
advancrd sufficiently to ensure rettab!e diwhninatbn between sit 
supraventrieutsr and ventricular arrhythmias. 
Two eases are pranted in which device-mediated pacing 
therapy, triggered by rupraventrtrular arrhythmias, induced 
ventrieulsr tachvcardia resuirinc additional therawutic intervene 
tton. This repwi Must&the ti;erapoutic versatiiity and some or 
the potential pitfalls, of the recently developed devicesand reviews 
the status ofautomatic arrhythmia identification technology. 
(f Am Coil Cmdi~l1991;18:141.&25j 
The t%st repor! (11 of Ihe use of an automatic implantable 
defibrillator for the prevention of sudden arrhythmic death 
appeared in December IY80 and described its use in three 
patients. In the short period of IO years. devices of this kind 
have become an integral part of the therapy for malignant 
arrhythmias and the prevention of cudden death (2.3). As 
technolagic advances are made. the clinical appbcefion of 
antiarrhythmic deuces will likely expand. Incorporation of 
antitachycardia pacing and low volwge cardioversion capa- 
bilides, which offer the option of less painful electrical 
therap) for ventricular arrh;thmias. will encourage the use 
of the% devices in patients wirh frequent episodes of ven- 
tricular tachycardia and in those whore txhycardia does not 
produce loss of conxiowness. These new devices will he 
programmed more often to treat slower tachycardia. How- 
ever. the lower cutoR rate will increase the rigk of misdi- 
rected electrical therapy during supraventricular tachycar- 
dia. bccauae the technology required to automatically 
discriminate supraventricular from ventricular rhythm is still 
limited in all devices of this kind. Such a response, in 
addition to being misdirected. may itself prec~pitax venlric- 
ular arrhythmur. 
The case reports that follow illustrate some of the prob- 
lems that may occur when treatment options expand more 
rapidly than improvements in diagnostic specificity for ven- 
triculararrhyfhmis. New techniques that may enhance diag- 
nostic capability are discussed, with special attention to the 
limitations of each technique. 
cusc I 
Case Reports 
History and findings. A 43.year old woman WPF admitted 
for evaluation ofwell tolerated sustained uniform ventricular 
tachycardia that occurred while she WBF taking quinidine to 
prevent atrial fibrillation. Thirty-two months before the 
onset of ventricular tachycardia she had had a second mitral 
valve replacement for rheumatic mitral stenosis and regur- 
gitation. which was complicated by a perioperative infero- 
lateral myocardial infarction. 
AI Ihr rbnp of ker hnsclinr clrcrropkysinlopic andy. two 
patterns of sustained ventricular tachycardia were induced 
wth a cycle length of 240 to 260 ms (230 to 250 bestslmin). 
Ventricular tachycardia was still inducible and marginally 
tolerated during subsequent electrophysiologic tenting while 
the patient ~8s receiving procainamide. quinidine plus mex- 
iletine. and amiodarone therapy. However, with these 
agents the ventricular tachycardia was slower (cycle length 
350 to 420 ms) and readily terminated by extrastimuli and 
overdrive pacing. Oral therapy with procainamide WBE insti- 
tuted. and treatment with an antitachycardia pacing device 
was planned. 
Implantation of csrdioverter~efibrillator. An invesdga 
tional automatic cardiaverter-defibrillator with antitachycar- 
dia pacing capabilities (Cadence. Ventritex) was implanted 
by way of a left lateral thoracotomy. utilizing two large 
delibrillating pavhes over the epicardwm. ,md iw epicar- 
dial xrew-in sensing--pacing electrodes in a bipolar confip- 
uralion near the lef, ventrtcular apex The dewce R% 
programmed to diagnose ventricular fibrdlat~on aben :I mm 
imwn of I? RR intervals from \en\ed eoicard~al actwn\ had 
a mean cycle length <320 mu. The mean cycle len& I\ 
calculated from the four moct recent cvcIc\ and updated wth 
every beat. Once ventricular Rbrdlation w.is detected. the 
device was programmed 10 deliver a defihrdlaring shock of 
500 V wrh five backup shockc of 150 V each. as needed. to 
restore a normal rhythm. In addmoo. the dewcc >\a% pro- 
grammed to diagnohc ventricula- tachycwd~a nhen a mtm- 
mum of eight RR mtcrval~ wth a mean cyc!c lcnglh ~170 rn\ 
occurred. The cutoff rate for twhycardla dercctlon aas 
above ,he palient’s maximal ‘ere;we-mduced heart rate 
(I21 beats/&n) determined by treadmill testing before im- 
plantation of the cardiover:cr.defibrillaior. but below the 
;a,e of her ~Iowest induced .~~,ricular txhyuardia. The 
criteria for tachycardia detection also recioired an abrupt 
onset of the arrhythmia. ac typically occurc wtth an episode 
of ventricular rachycardia rather ,han the more gradual onw 
expected of a sinus tachycardia (41. The wdden onW delta 
(the required change in mean tachycwdia cwle length) 15 
programmable from 50 to SW ms in Ihe Cadence devee. and 
was programmed in this case 10 I50 mr. 
71~ pro~mmnwd n,,rimcl~n ardio rholrp~ c orrrirml (!I 
nstonmic de-crwnoerd hsr.m of eiKl!r wr~ud~ W/I d~~c,r- 
~nent~d scnn!tin#. The first impulse of each hunt rva< to he 
delivered coincident with the sensed epicardia, electragram 
and the second impulse of :be mitie! b”n! z! a coopline_ 
interval equal to 80% of the spontaneous tachycardi. cyc!e 
length; subsequent coupling intervals within each bun, 
would decrease by IO-ms decrements. A total of vx decre- 
mental bursts of anlitachycardia pacing would be delivcrcd. 
if needed, to restore a normal rhythm. The first coupling 
interval ofeach of the 6 bunts would decrease by 10 ms. If 
antitachycardia pacing was unsucce~sf”l. the device was 
programmed to deliver a 100-V qhock. followed by one 
backup shock of 500 V and two %hock\ of 750 V each. .I< 
needed. to restore normal rhythm. In the event of tachycar- 
dia acceleration during antitachycardia pxing. the dewce I\ 
capable of shifting to defibrillation therapy once fibnllatlon 
rate criteria arc satisfied. 
E&c, of postoperative paror)nma, a,ria, libri,,a,ion. 
Rutter. Three days after tmplantation of the device. the 
patient developed atnal fibrillation-flutler with a mc”” vcn- 
tricularresponse of IS0 beatrlmin (cycle length 300 m9 ,Fig 
IAI. The abrupt ““set of tachycnrdi” at a rate of 150 heat</ 
min met the programmed criteria for detection of ventr~lw 
tachvcardia. and the device initiated antilochvcsrdta wac~ne 
therapy (Fig. IS). The fin1 decremental hwt induced v&T 
tricular lachvcardia at B cvclc lcncth of Xi “15 ,160 heaw _ 
mini. which was interpreted by the u&e a\ ongllinp 
tachycardia A wcood dccrcmcnt;d hunt did no1 termmate 
the ventricular txhycardia. hut a third attempt rcwltcd I” 
reueniw to “trial fibrillation-flutter : Fig. ID). Besau\e the 
don. ,he device still perceived it as a fzailure of therapy and 
delivered a fourth decremental burst. Once more ventricular 
whycardla wai Induced. initially al a very rapid rate of230 
bsatslmin tcyclc length 260 ms). but slowing 10 IhObeatrlmin 
after 9 beat* IFif. lEl. Thi, was an insufficient number of 
cycle\ witha meancyclelcnglh <32Omsl>188 bcatslmin) 10 
satnfy the detection crilena for ventradar fibrillation. The 
device. Iherefore. continued its antitachycardic pacing pro- 
tocol. delivering a fiflh decrcmen;al burst. The first couplinn 
~mterval was now 40 ms <80% of the initial tachycardia cycle 
lenglh. This rapid burst rranriently accelerated the tachycar- 
dia to a rate of 250 bcatslmin (cycle length 240 msl (Fig. I FL 
whxh war followed by reverclon to atria1 fibrillation-flutter 
after 13 complexes. The epiwde of nonsustained ventricular 
tachycardia was fast enough and long enough to meet the 
programmed criteria for detection of ventricular fibrillation. 
Thu\. a 5WV dcfib;illatmg shock wa, delivered dzrizg atrial 
fibrillation-flutter while Ihe pabent was fully awake and 
mimmallv wmdomatic. This shock finall! restored normal 
sinus rhythm u&h a rate <I28 bratslmin (Fig. ICI. 
The device conlinuou~ly monitors the rate until delivery 
of dehbrdlation therapy. This feature allows therapy to be 
aborted. preventing an inappropriate shock after the spon- 
taneou~ termination of rapid tachycardia. Hut in the present 
CRIC. the rate of aria1 fibrillation-flutter after nonsuslained 
ventricular tachycardia remained above the cutotT rate for 
ventricular lachycardia detection. As programmed. the de- 
vice doe\ not reduce ils lcvcl of lherapy unlil all tachyar- 
rhylhmiss are lerminated. Therefore. in lhis inslance. it was 
committed to proceed with defibrillation therapy as long as 
any rhythm faster than 128 bealsimin persisted. 
A shon time later. before the device was reprogrammed. 
a recand episode of atrial fibrillation-flutter occurred with a 
ventricular response of I40 beatsimin (Fig. ZA and 3). 
Tachycardra was detected by the device and anlilachycardia 
pacing was initiated in the absence of ventricular tachycardia 
(Fig. 28). The first decremental burst induced ventricular 
tachycardia at a rate of 160 bealslmin, which was succcss- 
fully converted to normal sinus rhythm by the second 
decremental burst (Fig. 20. Finally, a third episode of atrial 
Rbrdlation-flutter occurred. with a venlricular response of 
I60 bealslmin [cycle lenglh 375 ms) (Fig. 4A and 5,. and was 
similarly treated with anlitachycardia pacing by the device. 
The hrst decremental burst induced a raoid venlricular 
tachycardia at a rate of 230 beatsimin (Fig. 481. Appropriate 
defibrillation therapy consisted of a 500-V shock effectively 
restored normal yinus rhythm (Fig. 4, C and D). 
Trealment and patient follow.up. The device was repro- 
grammed to higher cutoff rates. 160 bearsimin for detection 
of ventricular tachvcardia and 200 beatsimin for detection of 
ventricular fibrilla&n. The criteria for venlricular fibrillation 
detection of were made more risorous. reauirine a minimum 
of I6 cycles at a mean cycle le&h of& m%?his “slow” 
rate of fibrillation detection allowed the device to wilhhold 
treatment of brief. nonsustained episodes of rapid ventricu- 
lar tachycardia. such as those shown in Figure I. In addition. 
the patient was treated with digoxin and low doses of 
propranolol LO control venlricular response to atrial librilla- 
Figure 1. Care I knelr A to C show B cantinuous 25-s segment 
from rhc amc Hoher monitor recording gee” in Figure I. In panel A. 
atrial Bbrillation-Rater (A FIRIW with a venlricular re\ponie of 
140 beatrimin beg;m abruptly during normal smus rhythm INSRI. 
Panel R. The criteria for lachycardiadetecdon were wtiskd and !he 
device initiated antitachycardia pacing with a decremental burr! of 
eight impuhea (srrowsL Ar programmed. the coupling interval of 
the first two paced impulsesequaled MT (330ms)ofthctaehycanlia 
cycle length and each rubwquenl coupling interval within the burst 
was decreawd by 10 mb. Panel C. A second succesful burst of 
antitachycardta pacmg wa< delivered. Abbrevialions as in Figure I. 
lion-flutter. All other antiarrhylhmic drug therapy was 
stopped. 
At the time of subsequent electrophysiologic tesling. 
which was oeriormed noninvasivelv bv utilizinc the oacinc 
capabilitiesbf the device. all inducibk~ventricuiar lac’hyca~ 
diss had rates treater than 190 bealslmin Icycle length 
320 ms). As ares&. Ihe cutoff rate for lachycardia deteclion 
was increased to I71 beasslmin (cycle length 350 mr). 
Ahhough one addilional episode of alrial fibrillation-flutter 
was documented electmcardio.graphicaIly. the ventricular 
response was only I IO beatslmin. There were no further 
inctances of therapy by the device durins IO months of 
follow-up. 
caw 2 
Hibry and findings. A 67.year old man was admitted for 
evaluation of sustained ventricular lachycardla (cycle length 
320 ms) requiring cardiovenion. He had a history of multiple 
myocwdial infarctions and a left ventricular ejection fraction 
of IN% During baseline electrophysiologic testing. vcntric- 
ular tachycardia (cycle length 250 10 290 ms) requiring 
cardioversion was induced. An atrial tachycardia (cycle 
lenglh 310 to 370 msl that had no1 been observed clinically 
wa, also induced with atrial stimulalion. Ventricular why 
cardia was still inducible during subsequent electrophysio- 
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Figure 1. Caw I. Pm& A to c show Pplcardlal eleCIr”~rdmr 
recorded simultaneously from the pacmg-smug ledd- durm~ the I ,ur a 
sdme arrhylhmia rpiaudc a\ lhnt displayed an Fwrc ? Note Ihd Ihc Figure 4. c ./\C I Pm4* 4 f” ” \bU :I C,ml,n”o”\ 3” \ \q”lml 
electm~ramconflgunt~ondunn~~tlwl hhrillaoon-Rutterl4 FIB’FLI from IhC wme HdLY man,ti~rrcc”rdlnpw” in ‘he prerln”I RC”W\ 
i\ identical to that seen during normal Gwi rhylhm INSR). ha, I\ Pane, -\ -\tr~:~i hbnlkmun-luorr (4 FlRFt 1 uith 2) ~e”t&ul.~r 
rignilcandy diRerent bn (ha! see” during w”triwlw rrchycardm 
,W 8, the end of panel 8. rc\po”\c of Ih” ire.“,‘““” hcga” .d,rup,l\ dump. ““imal v”“\ rh!lhm IUSRI. F’anrl B. The ~r”rr~.t 1x ,.srh,crrd~~ dewclio” mere 
w,,,ficd ,,“d ,hc de\,cr ,n,rialed a”ta.,shycxd,a ,XCTC n”h n 
logic testing. whet, the pattent was raking either procnmnmde 
decremcnu bw! idr~ph! !mpulw larrowl Thh Hun, prodo~~! :I
r.npid ~eom~l~r ~.,chyc:sdl.~ (VT) Panpt I? The drx~c dchrrrcd 
or quinidine plus mexiletine. but it was slower (cycle length dchhriii:~oon rhw.,p! conwong of :I W-V rhorl. nilh rerum uf 
420 to 520 ms). well tolerated and readdy terminated hy normal \,nur rhjthmshwn in pawtf~ “F = \cn,n~u,:,r fihnlkmnn. 
programmed wing. 
i,splantation oFcardioverler.defibriilator. The palien, re- 
mained on a regilr;? of quinidmc plus mcxilctinc and do ofi~n,i,;ch~uilrdi;! pacing. cnch wsh o cycle lenglh IO m< le\s 
automatic cardioverter-defibrillatur wit!! antitachycardia than ,bat of the preview bun,. would bc dcliwred. if 
pacing capabilities (Cadencel was implantea. The device needed. 10 rwtore ;I normal rhythm. If the five hura of 
was inserted by way ofa left laterot thoracotomy. wirh we of nntoach~card~a pacing d!d not restore normal rhythm. the 
two large detibrillating parches placed over Ihe epicardium device wa\ programmed to deliver a 400-V shock followed 
and one endocardial sensing-pacing electrode positioned m by one 550-V nod two 7%V backup \hock\. as needed. to 
the right ventricular apex. Introoperatively. the Gnoc cycle re\,ore norm,, rhylhm. In add,&,“. after 40 c of cormrwoo~ 
length was 780 ms and ventricular tachycsrdia uith a cycle tachywrdet. the device was programmed 10 deliver defihnl- 
length of 320 to 540 on t I I I to I88 beardmint wils inducible. Moo Iherspy. \(I that trials of antilachycardia therapy 
The duke IWS pro~,wwwd to diagnoce ventricular would never pcr\is, beyond a 40-s limit during any given 
fibrillation when a minimum of I? RR imrrvals it, a mean cpnode of rahycardia This feature. called extended high 
cycle length <300ms occurred. and todelivero defibrillating rate de,ec,ion. )\ progmmmable between IO s and 5 min. ;md 
shock of 550 V followed by five backup \hock5 of 750 V I\ designed to place XI upper limi, oo ,he duration of 
each. as needed. to restore a normal rhythm. In addmon. the tachycardL. ixflerwhich thedevice proceeds to defibrilkuion 
device WBS prognmmed ,o diagnose venlriculor tachycardm therapy. whrthcr or not the programmed anwxhycardm 
when a minimum of eight internills a, a meon cycle length protocol ho\ heen completed. 
<550 ms occurred. This cycle length was *elected hecauze of Elfect of pastoperatire sinus and supnv~nlricular Iachy- 
the long ventricular tnchycardia cycle lenprh ohcerved :n,ra- cnrdias. Within ;S day after device ~mplanlnlion. the pa,!eot 
operatively. Tbe programmed anotachycardm lherapy con- developed a rinui mchyuardra d, a cycle length of 4W 111, 
sis,ed ofburrts of I? rumuli. imtially debvcred a, 35% ofrhc wth a left hundle branch hluck abermtmn IFig. hAI. Al- 
spon,aneoo, lachycardrir cycle length. A lotid of five ho,\,\ lbooph the pouent wil\ minimally symptomalic. ,hls Iachy- 
cardia met the programmed criteria for ventricular tachycar- 
dia. and the device inmated antllachycardia therapy. A third 
burst of antitachycardia pacing induced ventr~colar tachy- 
cardla at a rate of 143 beatslmin (cycle length 420 rnsl. which 
was not termmated hy a fourth bunt (Fig. 6. C and DI. At 
this poinl the device recognized that continuous tachycardia 
had been present for 40 s and it shifted to defibrillation 
therapy. deliverinp a 550-V -hock (Fig. hE). Although this 
shock successfully terminated the ventricular tachycardia. 
the sinus tachycardia persiaed. caucing a repention of the 
preceding sequence of event3 before the device could bc 
deactwated. 
T/w dcGw n’nr rcp~opronmrd to R cumff rate of 
145 beatslmin (cycle length 415 ms) for ventricular txhycar- 
dia detection with the additional requirement of sudden 
onset la change in the mean cycle length P I50 mst to avoid 
the delivery of thcraw for \inur tachvcardia with a eradual 
incrcare in-rate. The‘&ent received &a more shoc‘ks over 
the h-week penod after hospital dlrcharge. These were 
dclwcred to treat probahlc supravcntricular tachycardia at a 
cvcle lencthof410nn 1146 bentriminl:fheclin~cal diarnooc 
&made from stored ventricular electrogramp. record‘ed by 
the &vice dlll-ing the :wrhythmi;a. which ufere morpholog!. 
c,dly identical to thow of sirw rhythm 15.6). 
The rupravmtriculor tachycardm ~8s thought to repre- 
dent the atrial tachycardia induced during basclinc clectro- 
physloloplc testing. We endeavored to increase the rate of 
the ventricular tachycardia by reducing the dose of quini- 
dine. and to decrease the incidence or &tricular re&ose 
rate. or both, of the patient’s supraventricular tachycardia 
by the addition of a beta-adrenergic blocking agent to hi5 
therapy. The patient has had no subrequcnt shocks during 
short-term follow-up. 
The<e two caes provide a good illustration of some of the 
recent advancer that have been made in antiarrhythmic 
device technology and some of the limitations that still 
complicate lhcir clinical application. The combination of 
antitachycardia pacing with low and high energy shock 
d&very as well as backup bradycardia pacing in a single 
device bar expanded the number of clinical situations in 
which such a device may appropriately be employed. 
Limitations of automatic arrhylhmia recognition. Along 
with the benefits of greater versatility in the treatment of 
slower ventricular arrhythmias. however, come limitations 
arrociated with inability to distinguish supraventricularfrom 
ventricular rachvcardiar in this ranee of loncercvcle leneths. 
The implicit goal in the design ofbefibrill&nis to e&e 
that they never fail to detect a lethal arrhythmia. Therefore, 
errors that occur tend toward overdiagnosis rather than 
underdiagnosis. and there is a risk of inappropriate delivery 
of therapy. Inappropriate therapy. as illustrated in the cases 
presented. may occarionally turn a benign supraventricular 
tnchycardia into a more serious venlricular arrhythmia, and 
may lead to an uncomfonable high energy shock. The 
accuracy of automatic arrhythmia diagnosis by the newer 
devices mu\t he improved to reduce the occurrence of 
unnecerrary delivery of therapy. In addition. physicians 
must be aware of the values and limitations of each added 
sensing criterion so that devices can he programmed to 
function optimally. 
Sudden onset and rate rtahilily sensing. The goal of im. 
proved diagnostic specificity oi antiarrhythmic devices has 
heen approached from several ddferent aspects. It i9 obvious 
from these are wdies that rate cr~leria alone are not 
wfiicient to discriminate between wpraventricular and ven- 
tricular tachycardiac. although the addition of sudden onset 
nr a requirement help\ to avoid confusion between exercise- 
induced sinus tachycardia and ventricular tachycardia. Nev- 
ertheless. as demonbtrdted in this report, supraventricular 
; I-i. i. i. i Ylrb, 
&I~v~n~r~cuI:~r conduclion delay. At a au~ravent&ular 
t,,chyc;,rd,;, qcle length of 4W m, lthe cycle lrqrh of the 
,~trrill lihrllkdiun-llutlcr in Fig. Il. cwn udhuut a further 
~CICIIL’ in CjRS durdlmn dunng tachycardia. the relalive 
i:nx ara) fium Ihe hrehnr would he approx,mately 38% of 
each qcic. \;mrfying the prubahdity denally function cnte- 
ri.g In Ihl* pahcn~ thcreforr. Ihe addluun of probahdlly 
Al&l irn$g. The rddilian of a” illrial senamg lead to 
ihe dcfihr,lli,t”r \ystcm may idlow ihc dlaga”r!r of\upraven- 
lriculrll ischycdrdra whco the wind rate 13 hsler than the 
wntrxul.w rateand there arc rsti”,of!:I. 3:I “rother amble 
r&o\ hclaecn anal and venlncular impulses (II). But 
arrhylhmi;i\ wlh a I:I AV relation may not he reliably 
dlatlngui\hcil from venlr~“lar lachycnrdia wilh retrograde 
conduction. and those uithoul a able AV relation (for 
cxamplc. aria1 fihnllalion. atrial flutter with variable con- 
duction or atrml tibrillation.flulter RS outed I” Patient II may 
not be di\tingr:irhahle from alrial and ventricular arrhyth- 
mia\ occurring concwrcntly. The dii?‘crcnwlion of aotcro- 
grade and rerrograde atrral activation ulilizing slope analysis 
of the wprxd, from one or fw nppropnalely placed alrial 
*coring lcadr (I?) ma) “lr an advanlagc I” the diagnosis of 
ventr~ular tachycdrdia wilh rctragnde venlriculodtridl con- 
duction. However. with carefill consideration it is clear that 
rhc vector of sctivali”n at a local atria1 eleclrogram \itc 
during AV nods reentry. during alridl ixhycardia from a low 
ariaI focu, and possibly even during atrlel flutter may bc 
mdlslmguishahlc from Ihc wetor of relrograde 81rnal actiw 
lion during venlricular lachycardia. 
Sensing ofclcrtrngram configuration and timing. Morpho- 
logic analyii$ of the lucal vcnlricular elcctrogrdm has also 
been prop”3ed a~ a meaw of differentiating wpraventricular 
heat\ from those “f vcnlri~uldr origin (13-151. The e”nlrw 
bclween eleclrugram\ recorded during wpravcntricular and 
venlricular tachycardia\ ix well demon\trdled in Figure 3. 
Howwcr. the lack of marked conlraal between the local 
electr”!xamr recorded during Ihe rupraventricular and vcn- 
Lriculdr w!hycdrdia% in Figure 5. causes some conecrn. A 
report of ldenucal local clectrograms occurring during N- 
pravenlricular and ventricular tachycardias in “nc patient 
(141 auggc*ta thri murphologlc erlterid illone may not be 
wfic~nl I”I the corrccl didgn”w*. In addition. the influcncc 
on lhwai ventricular elcwogrmn wnfigwalion ofrate-rclaled 
hundlc hr.mch dberrzation. and r8wclstcd changer in con- 
ducuun through ahnolmal tiwc hn\ not been addrewd 
\yrlematicdlly (161. These fdclors might complicate the 
dixrimmauon between rapld wpraventr~ular and vcntricu- 
lar wmplexe,. Furthermore. electrogram amplitude and 
configuration muy change I*ith wne aa acute local inllamma- 
tion and fibrow progrw ai the \ile al implenl;lr!“n. Changes 
I” left ~enlrn~ldr wall lhicknesr. &hernia. or new infarction 
may influence lhese \igoals a\ well. All of thex variahlcs 
need to be mveatisaled befure the reliable use of electrogram 
configuration can be employed a> an automated dwgnoslic 
ad 
A mote pwnki~i~ upprod~ ro oe~ot~rrd wrh~rhmin 
dngrmi.r may lie in the analysis of the rcldlive conduction 
times of two “r three Iowl electrognms recorded from atrial. 
right vcntriculilr. and left ventriculw sites ll7.18~. However. 
the abiliiy of thn technique to diacriminalr abcrrdntly con- 
ducted rupraven~icular rhythms from those of ventricular 
origin has not yet been Ehown. 
Use of aturcd clrctr~grams for physician interpretation of 
arrhythmias. Concerns about the “xfulnccc of electrogram 
signals m the auromatic diagnostic algonrhm of a device do 
not detract from the obvious value of these electrograms 
when slured bv the device and rclrieved later. The informs- 
tie” provided to the clinician by intracardiac tracings such as 
the ones recorded in Case I (Fig. 3 and 5) is invaluable. In 
the absence of surface ECG tracings, intracard!ac recordings 
provide the only reliable means ofdifferentiating appropriate 
(ventricular tachycardia or ventricular fibrillation present) 
from inappropriate (ventricular tachycardia or ventricular 
fibrillation absenl) device intervention. in the setting of a 
history of vague episodes of palpitation or a totally asymp 
Lomal~e event. In 8 recendy reported episode (19) of well 
documented rapid polymorphic ventricular tachycardia. 
which was promptly cardioverted by an implanted cardio- 
verier-defibrillator. ;hc palicnt was t&ally as~mptomatic up 
:” the time of the shack. The clinician might have assumed 
that the shock was inappropriately delivered, ifekctrograms 
recorded by the device during the event had not been 
retrievable. In addition, readjustments of the programmed 
detection and therapeutic variables of these devices arc 
made immensely cawcr by the stored recordings (including 
dates and times) of episodes occurring at home (5.6). 
Hcmodynamic sensing. Perhaps the most exciting pro- 
posal for enhancing the detection criteria for dangerous 
arrhythmias has been the mcasurcmcnt of hemodynamic 
status by several means. Recordings from right ventricular 
intracavilary and left ventricular intramyocardial prcsowc 
sensors have been dcmonstmted in dogs and humans t” be 
good ma:kc:i for episodes of ~eid~2.i S:dllation (20). 
These variables might provide additional important criteria 
for delivering or withholding big% energy thempy in the 
diagnostic algorithms of antiarrhytbmic devices. If an ar- 
rhythmia is not hemodvnamically tolerated. it mieht be 
cardioverted rcgsrdlcsr of rate, wpraven:ricular “igin “- 
other less important faelors. Converacly. lack of hcmody 
namic compromise may allow 0” initial trial of antitachyca,. 
dia pacing or low energy \hock therapy in certain costs. 
reducing the incidcncc of unnecessmy high energy shocks 
wh as lh”>e seen I” our two cases. 
The human factor: preventive mcaswcs. Although a dc- 
vice that can distmguish bclwccn all supravenrricular and 
ventricular rhythms and determine the hemodynamic sta5 
of the patienl IS desirable. it is not yet availabic. Even with 
the improved diagnostic inturmalion available with the de. 
vice implanted in “ur IWO cases. il is obviuus lhat any device 
will “perate oplimtilly only if it is programmed 1” do so. The 
case, described underscore the imporrance of anticipating 
problems and of preventing suprdventricular tachycardiar 
that can lead 10 inapproprialc therapy. A detailed eval”ati”n 
performed before device implanldtion is necessary t” docu- 
ment Ihe maximal sinus rate during exercise. tbc cycle length 
of AV node Wenckebach block. the presence of an clcctro- 
miss and the mar, eNect,re man\ of ,ermmxion S,npprc,- 
uon of supraventricular arrhy1hmr.n *hauld he coniirmcd 
lion in the early p&operaGre p&od in all paricnlr under- 
going implantauon ofa card~ovcrrcr.dcfibr~Il;llur. In selected 
patienls rhe device may need 10 be Icmporxily deacliv~l~d. 
At the very least. the culoff rim tiir arrhythmra dclrction 
that results m shock thcraov rhould bc increased durine Ihi, 
techniques For immediate device deectiwtion should be 
providing the patienl’, exe. Administratmn of AV node 
blockingagent, should be considered powprratwcly and on 
a long-term basis in selected patient\ 10 decreme the vcn- 
tricular response to cupmvenlricular tech?cardu. In ,ome 
patients the dose of antiarrhythmic agent\ that &N the rate 
of ventricular tachycardia ma) be reduced. allorcmg grwlcr 
separadon of the rate of ventricular whyurdia from thal of 
s~pr~ventricular tachycardia. After any change in ami.\r- 
rhythmic therapy the etlicw oi the anlitachycardra pacing. 
protocol and delibrillation with the programmed rertingr 
musl be demonstrated. 
Conclusions. Although dcvicel mcvrpor.&ng rccem (sch. 
nologic advances can etTecrively treat uell roierarcd or 
frequent episodes of ventricular txhycardia. limintunx in 
device diagnortic capabilitier lead IO occa$xxill thcr;qxuuc 
errors. Incorporation of sudden onset Wang crilcn;l. con- 
tinuous sensing up to the time uf>huck delivery and retnev- 
able electrogram recordings can be helpful. However. lm- 
provement in arrhythmia detection and diagno& n 
neces~ry. and may reult from Ihe incorporauon into future 
antitachycardia device \ys~~s of addmonai awial or wn 
tricular sensing leads. or holh. more Gophnhcated amdni\ 
ofeleclrogram conligurat~on. and hcmodyn.mdc munit&. 
These advances may decrease the nrk of xrhythm,.~ 
misdiagnosis. For the present. however. II I\ ~mport.mt 10 
recognize an individual paGem’* wscepnhdity ICI wprwrn- 
lricular tachycardia lparricularly postoper;wcl) 1: to con- 
sider altering drug rhcrepy to wppreu rupmrwlricular 
lachycardla and 10 decrease 4V node conducuon. or idlou 
an increase in the rare of venlriclilar uchycardw or both: 
imd to program the cutoH‘ raw above Ihe Gnu\ rate al 
maximal exe&n and above Ihe rate of any coewting 
supraventricular lachycardia Finnily. cWrt* should bc 
made to identify pacing therapy. which 15 &e&e in lermi- 
naling vrnlricukr tachycardia hut Joe\ no! re.ldil\ mduce I!. 
